T. Rowe Price Investment Management, Inc.
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 1897612
BALTIMORE, MD
Position in CRNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$75,224,976
+$4,741,585 QoQ
Shares Held
2,010,288
+3.6% QoQ
Ownership
1.90%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#16
of 266 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026T. Rowe Price Investment Management, Inc. holds $12,244,164,567 across 51 Biotechnology names. CRNX ranks #30 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
6,754,846 | $1,801,652,525 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,642,173 | $1,698,463,338 | |
| 3 | CYTK |
Cytokinetics Inc
|
18,718,498 | $1,594,628,844 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
6,257,261 | $717,520,118 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
12,207,450 | $709,619,068 | |
| 6 | DYN |
Dyne Therapeutics, Inc.
|
30,912,287 | $686,561,894 | |
| 7 | CGON |
CG Oncology, Inc.
|
6,616,899 | $470,130,673 | |
| 8 | IMNM |
Immunome Inc.
|
19,676,883 | $416,953,150 |
All Filings in CRNX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $75,224,976 | 2,010,288 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $70,483,391 | 1,940,622 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,353,906 | 29,085 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,523,323 | 60,584 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $20,597,106 | 716,172 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $23,117,948 | 689,265 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $51,277,356 | 1,002,882 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $54,601,985 | 1,068,532 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $60,341,535 | 1,347,210 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $124,267,864 | 2,654,729 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $86,014,400 | 2,417,493 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $48,794,180 | 1,640,692 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $17,371,370 | 964,005 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $14,925,666 | 929,369 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||